Cinfa MD Discusses Biosimilar Products Approaching The Market
Executive Summary
At the 2017 BIO-Europe partnering meeting in Berlin, Germany, Ruediger Jankowsky managing director of Cinfa Biotech, talks about impending regulatory filings and decisions for its biosimilar drugs.
You may also be interested in...
Mundipharma Satisfies Appetite For Piece Of $4.5bn Pegfilgrastim Pie With Cinfa Biotech Buy
Mundipharma widens its biosimilar portfolio by acquiring Cinfa Biotech, and its soon-to-be-launched pegfilgrastim biosimilar.
Mundipharma Satisfies Appetite For Piece Of $4.5bn Pegfilgrastim Pie With Cinfa Biotech Buy
Mundipharma widens its biosimilar portfolio by acquiring Cinfa Biotech, and its soon-to-be-launched pegfilgrastim biosimilar.
TikoMed Seeks Partners For Regenerative Meds Pipeline
Tikomed CEO Adam Bruce talks to Scrip about the next steps for his company as it looks for partners to move forward with two clinical-stage programs.